Published: 2025-03-24 15:10:00 CET
Siguldas CMAS - Annual Financial Report
JSC ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija' Audited Annual Report for 2024
The Company’s net turnover in 2024 was 1.7 million euros, which is by 118.8 thousand euros or 7.7% more than in 2023.
The proportionality of the income from the basic occupation has slightly changed compared to 2023 – revenue from the sale of goods and services in the genetics industry has increased and accounted for 75.2% of the net turnover, while the income from the services of milk analysis and monitoring data processing has decreased - they totalled 19.3% from net turnover.
2024 ended with a profit of 80.8 thousand euros. Compared to 2023, the profit before taxes for the reporting year has increased by 15.6 thousand euros.
JSC ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija’ is the only producer of high-quality breeding bull semen and one of the largest suppliers of it in Latvia. The second largest field of the Company’s basic economic activities is the milk testing services. The Company also provides other breeding related services – consultations on issues of cattle breeding, feeding and keeping, evaluation of cow exterior, artificial insemination of cows, initial processing of the supervisory data. The Company offers Latvian farms to test genome samples of herd animals in the US genetics laboratory.
Valda Mālniece
Member of the Management Board, Manager of the Financial and Accounting department
E-mail: valda.malniece@sigmas.lv

Attachments:
Siguldas_CMAS_remuneration_report_ 2024.pdf
https://attachment.news.eu.nasdaq.com/af416a3a55b91c08024da569ab306b5fe
Auditor report_Siguldas_CMAS_2024_EN_translate.pdf
https://attachment.news.eu.nasdaq.com/a550a744e7ced73586fdaff75df173d50
Siguldas_CMAS_Annual_report_for_2024.pdf
https://attachment.news.eu.nasdaq.com/ac2fb3a15dba65810331b6a74462d3908
Siguldas_CMAS_Corporate_Governance_report_2024.pdf
https://attachment.news.eu.nasdaq.com/ad2082590d8fc688cc2d04834f7bdbc16
Subscribe
© 2025, Nasdaq, Inc. All Rights Reserved.